Superiority of extended neoadjuvant chemotherapy with gemcitabine in pancreatic cancer: A comparative analysis in a clinically adapted orthotopic xenotransplantation model in SCID beige mice

Cancer Biology and Therapy

Volumn 6, Issue 8, 2007, Pages 1238-1243

  Egberts, Jan Hendrik ^a   Schniewind, Bodo ^a   Sipos, Bence ^a   Hinz, Sebastian ^a   Kalthoff, Holger ^a   Tepel, Jürgen ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Murine orthotopic xenotransplantation model; Neoadjuvant treatment; Pancreas resection model; Pancreatic carcinoma; PancTu1 cells

Indexed keywords

GEMCITABINE; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; PANCREAS CANCER; PANCREAS RESECTION; SCID MOUSE; XENOTRANSPLANTATION; ADJUVANT THERAPY; ANIMAL; CANCER TRANSPLANTATION; COMPARATIVE STUDY; DISEASE MODEL; METHODOLOGY; MOUSE MUTANT; PANCREAS TUMOR; PATHOLOGY; XENOGRAFT;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYCYTIDINE; DISEASE MODELS, ANIMAL; MICE; MICE, SCID; NEOADJUVANT THERAPY; NEOPLASM TRANSPLANTATION; PANCREATECTOMY; PANCREATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 39749093836     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.6.8.4414     Document Type: Article

References (57)